IL-7 Promotes T Cell Proliferation Through Destabilization of P27Kip1

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2006 Feb 24

PMID 16492801

Citations 52

Authors

Wen Qing Li

Qiong Jiang

Eiman Aleem

Philipp Kaldis

Annette R Khaled

Scott K Durum

Affiliations

Soon will be listed here.

Abstract

Interleukin (IL)-7 is required for survival and homeostatic proliferation of T lymphocytes. The survival effect of IL-7 is primarily through regulation of Bcl-2 family members; however, the proliferative mechanism is unclear. It has not been determined whether the IL-7 receptor actually delivers a proliferative signal or whether, by promoting survival, proliferation results from signals other than the IL-7 receptor. We show that in an IL-7-dependent T cell line, cells protected from apoptosis nevertheless underwent cell cycle arrest after IL-7 withdrawal. This arrest was accompanied by up-regulation of the cyclin-dependent kinase inhibitor p27Kip1 through a posttranslational mechanism. Overexpression of p27Kip1 induced G1 arrest in the presence of IL-7, whereas knockdown of p27Kip1 by small interfering RNA promoted S phase entry after IL-7 withdrawal. CD4 or CD8 T cells transferred into IL-7-deficient hosts underwent G1 arrest, whereas 27Kip1-deficient T cells underwent proliferation. We observed that IL-7 withdrawal activated protein kinase C (PKC)theta and that inhibition of PKCtheta with a pharmacological inhibitor completely blocked the rise of p27Kip1 and rescued cells from G1 arrest. The conventional pathway to breakdown of p27Kip1 is mediated by S phase kinase-associated protein 2; however, our evidence suggests that PKCtheta acts via a distinct, unknown pathway inducing G1 arrest after IL-7 withdrawal from T cells. Hence, IL-7 maintains T cell proliferation through a novel pathway of p27Kip1 regulation.

Citing Articles

TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome.

Messerschmidt J, Azin M, Dempsey K, Demehri S JCI Insight. 2023; 8(13).

PMID: 37427591 PMC: 10371333. DOI: 10.1172/jci.insight.160690.

IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?.

Zhao Y, Wei K, Chi H, Xia Z, Li X Front Immunol. 2022; 13:1022808.

PMID: 36389666 PMC: 9650235. DOI: 10.3389/fimmu.2022.1022808.

Lymphopenia and Mechanisms of T-Cell Regeneration.

Saidakova E Cell tissue biol. 2022; 16(4):302-311.

PMID: 35967247 PMC: 9358362. DOI: 10.1134/S1990519X2204006X.

Diagnosis and Treatment of a Patient With Severe Combined Immunodeficiency Due to a Novel Homozygous Mutation in the IL-7Rα Chain.

Mansour R, El Bsat Y, Fadel A, El-Orfali Y, Noun D, Tarek N Front Immunol. 2022; 13:867837.

PMID: 35418989 PMC: 8996178. DOI: 10.3389/fimmu.2022.867837.

The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines.

Huang J, Long Z, Jia R, Wang M, Zhu D, Liu M Front Immunol. 2021; 12:680442.

PMID: 34956167 PMC: 8702497. DOI: 10.3389/fimmu.2021.680442.

References

Mohapatra S, Agrawal D, Pledger W . p27Kip1 regulates T cell proliferation. J Biol Chem. 2001; 276(24):21976-83. DOI: 10.1074/jbc.M009788200. View

Vucenik I, Ramakrishna G, Tantivejkul K, Anderson L, Ramljak D . Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation. Breast Cancer Res Treat. 2005; 91(1):35-45. DOI: 10.1007/s10549-004-6456-5. View

Spruck C, Strohmaier H, Watson M, Smith A, Ryan A, Krek T . A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell. 2001; 7(3):639-50. DOI: 10.1016/s1097-2765(01)00210-6. View

Harper J . Protein destruction: adapting roles for Cks proteins. Curr Biol. 2001; 11(11):R431-5. DOI: 10.1016/s0960-9822(01)00253-6. View

Barata J, Cardoso A, Nadler L, Boussiotis V . Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1). Blood. 2001; 98(5):1524-31. DOI: 10.1182/blood.v98.5.1524. View

Malek N, Sundberg H, McGrew S, Nakayama K, Kyriakides T, Roberts J . A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature. 2001; 413(6853):323-7. DOI: 10.1038/35095083. View

Hara T, Kamura T, Oshikawa K, Hatakeyama S, Nakayama K . Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem. 2001; 276(52):48937-43. DOI: 10.1074/jbc.M107274200. View

Isakov N, Altman A . Protein kinase C(theta) in T cell activation. Annu Rev Immunol. 2002; 20:761-94. DOI: 10.1146/annurev.immunol.20.100301.064807. View

Stahl M, Dijkers P, Kops G, Lens S, Coffer P, Burgering B . The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol. 2002; 168(10):5024-31. DOI: 10.4049/jimmunol.168.10.5024. View

10.

Tan J, Ernst B, Kieper W, Leroy E, Sprent J, Surh C . Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med. 2002; 195(12):1523-32. PMC: 2193564. DOI: 10.1084/jem.20020066. View

11.

Shin I, Yakes F, Rojo F, Shin N, Bakin A, Baselga J . PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med. 2002; 8(10):1145-52. DOI: 10.1038/nm759. View

12.

Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor M, Han K . PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med. 2002; 8(10):1153-60. DOI: 10.1038/nm761. View

13.

Viglietto G, Motti M, Bruni P, Melillo R, DAlessio A, Califano D . Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med. 2002; 8(10):1136-44. DOI: 10.1038/nm762. View

14.

Khaled A, Li W, Huang J, Fry T, Khaled A, Mackall C . Bax deficiency partially corrects interleukin-7 receptor alpha deficiency. Immunity. 2002; 17(5):561-73. DOI: 10.1016/s1074-7613(02)00450-8. View

15.

Kieper W, Jameson S . Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci U S A. 1999; 96(23):13306-11. PMC: 23943. DOI: 10.1073/pnas.96.23.13306. View

16.

Carrano A, Eytan E, Hershko A, Pagano M . SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999; 1(4):193-9. DOI: 10.1038/12013. View

17.

Ishida N, Kitagawa M, Hatakeyama S, Nakayama K . Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J Biol Chem. 2000; 275(33):25146-54. DOI: 10.1074/jbc.M001144200. View

18.

Frey M, Clark J, Leontieva O, Uronis J, Black A, Black J . Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol. 2000; 151(4):763-78. PMC: 2169440. DOI: 10.1083/jcb.151.4.763. View

19.

Dijkers P, Medema R, Pals C, Banerji L, Thomas N, Lam E . Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol. 2000; 20(24):9138-48. PMC: 102172. DOI: 10.1128/MCB.20.24.9138-9148.2000. View

20.

Tsukiyama T, Ishida N, Shirane M, Minamishima Y, Hatakeyama S, Kitagawa M . Down-regulation of p27Kip1 expression is required for development and function of T cells. J Immunol. 2000; 166(1):304-12. DOI: 10.4049/jimmunol.166.1.304. View